Boeing Jumps, Janux Therapeutics Plunges, Signet Slides
- Boeing (BA) shares advanced as much as 9.2% after Malave’s comments, which provided the first detailed look at the planemaker’s cash projections for 2026. The company expects to generate cash again in 2026, with positive free cash flow to reach the “low-single digits” billions of dollars. They still expect to eventually reach the $10 billion cash-generation target outlined by the previous management team, according to Boeing Chief Financial Officer Jay Malave.- Janux Therapeutics (JANX) shares plunge 41% in premarket trading, after the drug developer gave interim…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.